Food Testing MarketSize, Share & Industry Analysis, 2026-2034By TypeBy ApplicationBy Testing TypeBy Food TestedBy Service Provider

Food testing covers the analytical services and instrumentation used to verify that raw ingredients, processed foods, and beverages are safe for consumption and meet regulatory and label claims before they reach a retail shelf or export market. It spans microbiological, chemical, and physical testing performed in commercial laboratories, in-house quality-control facilities, and government or independent certification bodies. Buyers range from food and beverage processors and packers to retailers, exporters, and regulatory agencies that require documented proof of compliance before a shipment or product line can be sold.

Growth of 8.1% a year carries the global food testing market from USD 25.6 billion in 2025 to USD 51.66 billion in 2034. The full series behind that rate covers USD 16.9 billion in 2020, USD 23.7 billion in 2024, USD 27.7 billion in 2026 and USD 37.84 billion in 2030, with 2025 as the base year.

On the type axis, growth rates run from 6.76% for Immunoassay Systems up to 10.67% for Mass Spectrometry Systems. Immunoassay Systems carries the volume: USD 10.88 billion and 42.5% of revenue in 2025, USD 19.631 billion and 38% in 2034. Share moves toward Mass Spectrometry Systems and away from Immunoassay Systems and Chromatography Systems, though no line shrinks in revenue terms.

By application, Food Processing Plants accounts for 58% of 2025 revenue at USD 14.848 billion, reaching USD 29.446 billion and 57% by 2034. Food Safety Institutions grows faster at 9.4% against 7.86%, moving from 30% of revenue to 33% by 2034. This axis divides the same revenue as the type split rather than adding to it, so the two are read together rather than summed.

The regional order runs from North America at 31.57% of 2025 revenue down to Middle East and Africa at 6%. North America is worth USD 8.082 billion in 2025 and USD 14.981 billion in 2034; Asia Pacific, second at 28.5%, moves from USD 7.296 billion to USD 17.048 billion. Because Asia Pacific take share, the revenue added by 2034 concentrates rather than spreading across all five regions.

The 2025 total is arrived at by triangulating published aggregates against category proxies, not by an independent count. Segment, regional and country splits are estimated on the same basis, which bounds the precision of the figures above. Coverage runs to five regions, three type lines and five segmentation axes across a fifteen-year window.

• Revenue grows from USD 25.6 billion in 2025 to USD 51.66 billion in 2034, a compound annual rate of 8.1%, having reached USD 23.7 billion in 2024 from USD 16.9 billion in 2020.
• Immunoassay Systems is the largest type line at USD 10.88 billion in 2025, a 42.5% share, reaching USD 19.631 billion and 38% of revenue by 2034.
• Fastest growth on the type axis belongs to Mass Spectrometry Systems: 10.67% a year, USD 6.198 billion to USD 15.498 billion, and a share moving from 24.21% to 30%.
• The bull case puts 2034 revenue at USD 56.83 billion and the bear case at USD 46.49 billion, either side of the USD 51.66 billion base case, each with its own stated assumption in the full report.
• The largest region is North America, generating USD 8.082 billion in 2025 (31.57% of the global total) and USD 14.981 billion by 2034, ahead of Asia Pacific at 28.5%.
• 80% of North America's base-year revenue comes from the United States alone: USD 6.466 billion in 2025, rising to USD 11.985 billion by 2034, which is why it is that region's worked example.
• Every line on all five segmentation axes and in each of the five regions carries its own revenue, share and growth rate for all fifteen years, 2020 through 2034, on a 2025 base.

Read across the forecast period, the global food testing market shows movement in three places: type composition, regional weight, and the 8.1% rate applied to the whole.

None of them reverses the market's direction. Every line and every region grows in absolute terms across the period; what changes is which of them captures the revenue added.

Mass Spectrometry Systems outpaces Immunoassay Systems. Mass Spectrometry Systems grows at 10.67% across 2026-2034 against 6.76% for Immunoassay Systems, the widest spread on the type axis. By 2034 the two sit at 30% and 38% of revenue, against 24.21% and 42.5% in 2025. Revenue rises on both sides; USD 6.198 billion to USD 15.498 billion and USD 10.88 billion to USD 19.631 billion respectively, so this is a change in composition, not a contraction, and one forecast window is long enough for it to matter.

Asia Pacific gain regional share. Asia Pacific moves from 28.5% of revenue in 2025 to 33% in 2034, worth USD 7.296 billion rising to USD 17.048 billion. Share moves off the others in turn: North America at 31.57% moving to 29%, Europe at 25.93% moving to 24%, Latin America at 8% moving to 8%, Middle East and Africa at 6% moving to 6%, each still growing in revenue terms. The practical consequence is that regional weighting decides whether a participant matches the market rate or trails it, regardless of how its own revenue reads.

The series never breaks trajectory. The market moves through USD 16.9 billion in 2020, USD 23.7 billion in 2024, USD 25.6 billion in 2025, USD 27.7 billion in 2026, USD 37.84 billion in 2030 and USD 51.66 billion in 2034. Against 8.66% through the historical period, the 8.1% forecast rate is a continuation; no year in the series interrupts it. That moves the planning question away from timing a turn and onto the type and regional mixes, where the actual movement is.

Growth is concentrated in Mass Spectrometry Systems

Separate the 8.1% into its parts and three show up: an already-large base compounding, the type mix moving toward its faster lines, and regional growth landing unevenly.

Downside case: USD 46.49 billion rather than USD 51.66 billion by 2034

What the bull case turns on

The total depends on a single line

USD 8.082 billion of 2025 revenue is generated in North America, 31.57% of the global food testing market rising to USD 14.981 billion in 2034. Among the five regions it ranks first by revenue in both years.

Its share moves to 29% by 2034, though revenue still rises throughout; what changes is the region's weight against faster-growing ones, which is not the same as weakening demand.

Within the region the type split tracks the global one; 42.5% of 2025 revenue in Immunoassay Systems, fastest growth of 10.67% in Mass Spectrometry Systems. Per-axis and per-country detail for North America sits in the full report.

The United States is the largest market within North America, generating USD 6.466 billion in 2025 and projected to reach USD 11.985 billion by 2034. At 80% of regional revenue in the base year it is not one market among several, the region's trajectory is largely this country's trajectory. Set against USD 8.082 billion and USD 14.981 billion for the region, it is why this market rather than a smaller one is the one reported in full.

Demand in the United States follows the type mix reported at global level: Immunoassay Systems is the largest line at 42.5% of 2025 revenue, moving to 38% by 2034, while Mass Spectrometry Systems grows fastest at 10.67% and takes its share from 24.21% to 30%. Because the country carries 80% of North America, a movement in its own mix shows up in the regional totals rather than being averaged away by neighbouring markets. The United States carries its own type breakdown in the full report.

In the United States, food testing laboratories and the suppliers who rely on them operate under the framework set out by the Food and Drug Administration together with the Department of Agriculture's Food Safety and Inspection Service, depending on the commodity class involved. The Food Safety Modernization Act shapes preventive-control expectations that testing must support, while the Federal Food, Drug, and Cosmetic Act underpins labeling and adulteration standards. Laboratories submitting data in support of regulatory decisions are generally expected to hold accreditation to the ISO/IEC standard governing testing and calibration competence, often administered through recognized national accreditation bodies. Suppliers must ensure methods are validated, results are traceable, and reporting aligns with the applicable agency's guidance documents before products move through interstate commerce.

SGS SA, Intertek Group plc, Eurofins Scientific, Bureau Veritas S.A, Silliker, ALS Ltd, Mérieux NutriSciences, TÜV SÜD, Microbac Laboratories, Neogen Corporation, Romer Labs and AsureQuality are the suppliers covered in the United States. Two different problems sit on the same axis: holding Immunoassay Systems at 42.5% of 2025 revenue, and taking Mass Spectrometry Systems while it grows at 10.67%. The full report covers country-level positioning and shares company by company; this summary does not.

Canada is sized at USD 1.616 billion in 2025, rising to USD 2.996 billion by 2034; 6.31% of global revenue and 20% of North America. It is reported separately from the United States across every segmentation axis in the full report.

Europe holds 25.93% of the global food testing market in 2025, worth USD 6.638 billion with USD 12.398 billion projected for 2034. By revenue it sits third across the study, and the ranking does not change between 2025 and 2034.

Its share moves to 24% by 2034, while nothing contracts here; other regions simply grow faster, which shows up as relative weight rather than as falling revenue.

The type mix reported at global level applies here, with Immunoassay Systems the largest line at 42.5% of 2025 revenue and Mass Spectrometry Systems the fastest-growing at 10.67%. Per-axis and per-country detail for Europe sits in the full report.

USD 2.124 billion of Europe's 2025 revenue is generated in Germany, the region's largest market, reaching USD 3.843 billion by 2034. It accounts for 32% of regional revenue in the base year, the largest single share without dominating the region outright. The region itself runs USD 6.638 billion to USD 12.398 billion over the same period, and this is the market carrying the country-level detail in the full report.

Composition here matches the global split: the largest line is Immunoassay Systems at 42.5% of 2025 revenue, easing to 38% by 2034, and the fastest is Mass Spectrometry Systems at 10.67%, from 24.21% to 30%. Its 32% weight in Europe means those movements carry straight into the regional totals. The full report reports Germany by type separately.

In Germany, food testing activity sits within the wider European Union food law framework, anchored by the EU General Food Law and enforced domestically through the Bundesamt für Verbraucherschutz und Lebensmittelsicherheit alongside state-level food monitoring authorities. Testing providers are expected to demonstrate impartiality and technical competence in line with the EN ISO/IEC standard for laboratory accreditation, typically overseen by the national accreditation body, DAkkS. Suppliers of testing services must apply validated methods aligned with Codex Alimentarius principles where relevant, maintain traceable documentation, and support labeling claims that satisfy both EU-wide requirements and any additional national provisions on food information to consumers. Non-conformities identified during official controls can trigger corrective action requirements before affected products may remain on the market.

The suppliers tracked in this study (SGS SA, Intertek Group plc, Eurofins Scientific, Bureau Veritas S.A, Silliker, ALS Ltd, Mérieux NutriSciences, TÜV SÜD, Microbac Laboratories, Neogen Corporation, Romer Labs and AsureQuality) compete in Germany across the type lines above. Immunoassay Systems, at 42.5% of 2025 revenue, is where the volume sits, and Mass Spectrometry Systems, growing at 10.67%, is where position changes hands over the forecast period.

7% of global revenue is generated in the United Kingdom; USD 1.792 billion in 2025, reaching USD 3.347 billion in 2034, and 27% of Europe.

5.7% of global revenue is generated in France; USD 1.46 billion in 2025, reaching USD 2.604 billion in 2034, and 22% of Europe.

In Asia Pacific, 28.5% of global revenue puts 2025 at USD 7.296 billion on the way to USD 17.048 billion by 2034. It is a leading region on this axis, second by revenue throughout the period.

33% of global revenue sits here by 2034, up from the 2025 level, on growth above the market's own 8.1%, and with a bigger contribution to the revenue added over the period than the base-year figure suggests.

Within the region the type split tracks the global one; 42.5% of 2025 revenue in Immunoassay Systems, fastest growth of 10.67% in Mass Spectrometry Systems. Per-axis and per-country detail for Asia Pacific sits in the full report.

The largest single market in Asia Pacific is China, at USD 2.772 billion in 2025 and USD 6.819 billion in 2034. Its 38% of base-year regional revenue leads the region, though enough sits elsewhere that Asia Pacific is not a proxy for it. Against regional totals of USD 7.296 billion in 2025 and USD 17.048 billion in 2034, it is the country the full report breaks out in detail.

The type pattern in China is the global one: 42.5% of 2025 revenue in Immunoassay Systems, 38% by 2034, against 10.67% growth in Mass Spectrometry Systems taking it from 24.21% to 30%. Its 38% weight in Asia Pacific means those movements carry straight into the regional totals. Revenue by type for China is reported separately in the full report.

In China, food testing falls under the oversight of the State Administration for Market Regulation, working alongside the National Health Commission on the development and enforcement of national food safety standards, commonly referenced as GB standards. Laboratories offering testing services are expected to obtain certification through the China Metrology Accreditation scheme and, where relevant, accreditation from the China National Accreditation Service for Conformity Assessment, demonstrating competence and impartiality. Suppliers must ensure that products are classified correctly under the applicable national standard, that testing methods match those prescribed or recognized by regulators, and that labeling and safety claims are consistent with verified results. Imported goods face additional customs and inspection requirements before distribution is permitted domestically.

SGS SA, Intertek Group plc, Eurofins Scientific, Bureau Veritas S.A, Silliker, ALS Ltd, Mérieux NutriSciences, TÜV SÜD, Microbac Laboratories, Neogen Corporation, Romer Labs and AsureQuality are the suppliers covered in China. Volume sits in Immunoassay Systems at 42.5% of 2025 revenue; movement sits in Mass Spectrometry Systems at 10.67% growth.

6.27% of global revenue is generated in India; USD 1.605 billion in 2025, reaching USD 4.262 billion in 2034, and 22% of Asia Pacific.

Within Asia Pacific, Japan accounts for 18% of regional revenue and 5.13% of the global total, worth USD 1.313 billion in 2025 and USD 2.728 billion by 2034.

USD 2.048 billion of 2025 revenue is generated in Latin America, 8% of the global food testing market rising to USD 4.133 billion in 2034. By revenue it sits fourth across the study, and the ranking does not change between 2025 and 2034.

Share settles at 8% in 2034, though revenue still rises throughout; what changes is the region's weight against faster-growing ones, which is not the same as weakening demand.

The type mix reported at global level applies here, with Immunoassay Systems the largest line at 42.5% of 2025 revenue and Mass Spectrometry Systems the fastest-growing at 10.67%. Per-axis and per-country detail for Latin America sits in the full report.

48% of Latin America's base-year revenue comes from Brazil; USD 0.983 billion, rising to USD 1.984 billion by 2034. Its 48% of base-year regional revenue leads the region, though enough sits elsewhere that Latin America is not a proxy for it. The region itself runs USD 2.048 billion to USD 4.133 billion over the same period, and this is the market carrying the country-level detail in the full report.

The type pattern in Brazil is the global one: 42.5% of 2025 revenue in Immunoassay Systems, 38% by 2034, against 10.67% growth in Mass Spectrometry Systems taking it from 24.21% to 30%. With 48% of Latin America concentrated here, a change in this country's mix is visible in the regional figures instead of being diluted by its neighbours. The full report reports Brazil by type separately.

In Brazil, food testing is governed principally by the Agência Nacional de Vigilância Sanitária, which sets health and safety requirements for food products, alongside the Ministério da Agricultura, Pecuária e Abastecimento for agricultural and animal-origin commodities. Laboratory competence is assessed against accreditation criteria maintained by the Instituto Nacional de Metrologia, Qualidade e Tecnologia, drawing on internationally recognized standards for testing and calibration bodies. Suppliers are required to classify products correctly, validate testing methods against the relevant regulatory framework, and ensure labeling reflects verified composition and safety data. Where products cross into export markets, conformity with destination-country requirements and Codex Alimentarius guidance is also expected, adding a further layer of documentation for testing providers to satisfy.

In Brazil the field is SGS SA, Intertek Group plc, Eurofins Scientific, Bureau Veritas S.A, Silliker, ALS Ltd, Mérieux NutriSciences, TÜV SÜD, Microbac Laboratories, Neogen Corporation, Romer Labs and AsureQuality. Two different problems sit on the same axis: holding Immunoassay Systems at 42.5% of 2025 revenue, and taking Mass Spectrometry Systems while it grows at 10.67%.

2.56% of global revenue is generated in Mexico; USD 0.655 billion in 2025, reaching USD 1.323 billion in 2034, and 32% of Latin America.

In Middle East and Africa, 6% of global revenue puts 2025 at USD 1.536 billion rising to USD 3.1 billion in 2034. Among the five regions it ranks fifth by revenue in both years.

By 2034 the share stands at 6%, though revenue still rises throughout; what changes is the region's weight against faster-growing ones, which is not the same as weakening demand.

The type mix reported at global level applies here, with Immunoassay Systems the largest line at 42.5% of 2025 revenue and Mass Spectrometry Systems the fastest-growing at 10.67%. Revenue for Middle East and Africa is broken out by every segmentation axis and by country in the full report.

The largest single market in Middle East and Africa is Saudi Arabia, at USD 0.538 billion in 2025 and USD 1.085 billion in 2034. Its 35% of base-year regional revenue leads the region, though enough sits elsewhere that Middle East and Africa is not a proxy for it. The region itself runs USD 1.536 billion to USD 3.1 billion over the same period, and this is the market carrying the country-level detail in the full report.

Composition here matches the global split: the largest line is Immunoassay Systems at 42.5% of 2025 revenue, easing to 38% by 2034, and the fastest is Mass Spectrometry Systems at 10.67%, from 24.21% to 30%. With 35% of Middle East and Africa concentrated here, a change in this country's mix is visible in the regional figures instead of being diluted by its neighbours. The full report reports Saudi Arabia by type separately.

In Saudi Arabia, the Saudi Food and Drug Authority sets the principal framework governing food testing, working in conjunction with the Saudi Standards, Metrology and Quality Organization and, at the regional level, standards issued through the Gulf Standardization Organization. Testing laboratories are expected to hold accreditation demonstrating competence and impartiality, generally aligned with internationally recognized standards for testing and calibration bodies. Suppliers must ensure that products are classified appropriately, that halal compliance is verified where applicable, and that labeling and safety claims match validated test results before goods reach the market. Imported food products face additional conformity assessment and customs verification steps administered through the kingdom's broader product safety program.

SGS SA, Intertek Group plc, Eurofins Scientific, Bureau Veritas S.A, Silliker, ALS Ltd, Mérieux NutriSciences, TÜV SÜD, Microbac Laboratories, Neogen Corporation, Romer Labs and AsureQuality are the suppliers covered in Saudi Arabia. The commercially relevant division is 42.5% of 2025 revenue in Immunoassay Systems, where the volume is, against 10.67% growth in Mass Spectrometry Systems, where share moves.

Within Middle East and Africa, South Africa accounts for 30% of regional revenue and 1.8% of the global total, worth USD 0.461 billion in 2025 and USD 0.93 billion by 2034.

Request this sample to see the full data tables and segment-level detail behind this analysis.

This report assesses the market across every segment, with revenue and a growth rate for each line in each year of the study period. It covers the drivers, trends, opportunities, restraints and challenges shaping growth, the competitive landscape and the companies profiled, and the research methodology behind every estimate. Segmentation is reported by Type, Application, Testing Type, Food Tested, Service Provider, and regional analysis covers North America, Europe, Asia Pacific, Latin America, Middle East and Africa, each broken out by country.